Avastin (Non-Small Cell Lung Cancer)：市場予測と分析（～2022）...市場調査レポートについてご紹介

1 Table of Contents
1 Table of Contents 5
1.1 List of Tables 7
2 Introduction 8
2.1 Catalyst 8
2.2 Related Reports 9
2.3 Upcoming Related Reports 11
3 Disease Overview 12
3.1 Etiology and Pathophysiology 12
3.1.1 Etiology 12
3.1.2 Pathophysiology and Histology 12
3.1.3 NSCLC Biomarkers 13
3.1.4 Quality of Life 14
3.2 Symptoms 15
4 Disease Management 17
4.1 Treatment Overview 17
4.1.1 Diagnosis 19
4.1.2 Clinical Staging 19
4.1.3 Screening and Early Detection 22
4.1.4 Localized Procedures and Therapies 23
4.1.5 Systemic Chemotherapy 24
4.1.6 Targeted Therapy 25
5 Competitive Assessment 28
5.1 Overview 28
5.2 Strategic Competitor Assessment 29
6 Avastin (bevacizumab) 32
6.1 Overview 32
6.2 Efficacy 34
6.3 Safety 35
6.4 SWOT Analysis 35
6.5 Forecast 36
7 Appendix 38
7.1 Bibliography 38
7.2 Abbreviations 43
7.3 Methodology 46
7.4 Forecasting Methodology 46
7.4.1 Number of NSCLC Patients Currently Seeking Treatment 46
7.4.2 Percent Drug-treated Patients 47
7.4.3 General Pricing Assumptions 47
7.4.4 Individual Drug Assumptions 50
7.4.5 Generic Erosion 51
7.5 Physicians and Specialists Included in This Study 51
7.6 Survey of Prescribing Physicians 53
7.7 About the Authors 53
7.7.1 Author 53
7.7.2 Epidemiologist 54
7.7.3 Global Head of Healthcare 55
7.8 About GlobalData 55
7.9 Disclaimer 56